Attys Want J&J CEO To Testify In Risperdal Breast-Growth Case

Law360, New York (September 18, 2012, 7:01 PM EDT) -- The CEO of Johnson & Johnson should be forced to testify in a trial alleging a boy developed breasts because of treatment with antipsychotic Risperdal, attorneys for the teen told a Philadelphia court Monday, saying the executive was intimately involved with off-label marketing to children.

The teenager’s case, one of more than 80 in Philadelphia against J&J unit Ortho-McNeil-Janssen Pharmaceuticals Inc., will be severely undermined if a jury can’t hear firsthand from CEO Alex Gorsky about his role in effort to boost sales of the controversial...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.